This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Frolov, A. Articles by Hui, D. Y. Search for Related Content PubMed PubMed Citation Articles by Frolov, A. Articles by Hui, D. Y. Related Collections Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:450.)
© 2007 American Heart Association, Inc.

Editorial

The Modern Art of Atherosclerosis

A Picture of Colorful Plants, Cholesterol, and Inflammation

Andrey Frolov; David Y. Hui

From the Department of Pathology and Laboratory Medicine, Genome Research Institute, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Correspondence to David Y. Hui, PhD, Department of Pathology and Genome Research Institute (ML 0507), University of Cincinnati, 2120 E. Galbraith Road, Cincinnati, OH 45237-0507. E-mail huidy@email.uc.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Atherosclerosis is a disease of large arteries that accounts for more than 50% of all deaths in the developed countries¹ and, according to the World Health Organization prediction, it will gain a status of the major morbidity cause worldwide by the year 2010.² Atherosclerosis is widely viewed as an inflammatory disease with hypercholesterolemia being a dominant underlying risk factor.^3,4 It is believed to be initiated by retention of LDL particles in the lesion-prone areas, which is followed by monocyte recruitment and their differentiation into cholesterol-laden macrophage foam cells.^1,5 Excessive cholesterol accumulation in macrophages exaggerates innate immune response that is manifested by upregulated production and secretion of inflammatory cytokines and chemokines, thus dramatically amplifying initial signal originated from the injured artery.⁶

See page 519

Despite the overall consensus on the causative roles of excessive cholesterol build-up and inflammation in the development and progression of atherosclerosis, the relationship between aberrant cholesterol metabolism and exaggerated innate immune response has not been totally established. Recent reports showing reduced inflammation in association with the cholesterol-lowering statin therapy provided indirect evidence linking cholesterol metabolism with regulation of immune response.⁷ However, this class of cholesterol lowering drugs not only inhibits cholesterol biosynthesis but also suppresses the synthesis of isoprenoids such as farnesyl pyrophosphate and geranylgeranyl pyrophosphate. Thus, inhibition of prenylation pathways such as those required for activation of Ras and Rho GTPase family proteins may be responsible for some of the cardiovascular benefits of statin therapy independent of its cholesterol-lowering effects.⁷ Among the most studied and understood . . . [Full Text of this Article]

Related Article:

Anthocyanin Prevents CD40-Activated Proinflammatory Signaling in Endothelial Cells by Regulating Cholesterol Distribution

Min Xia, Wenhua Ling, Huilian Zhu, Qing Wang, Jing Ma, Mengjun Hou, Zhihong Tang, Lan Li, and Qinyuan Ye
Arterioscler Thromb Vasc Biol 2007 27: 519-524. [Abstract] [Full Text] [PDF]